ALBERT DAVID Financial Statement Analysis
|
||
|
The Revenues of ALBERT DAVID have increased by 6.12% YoY .
The Earnings Per Share (EPS) of ALBERT DAVID has increased by 108.50 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
ALBERT DAVID Last 5 Annual Financial Results
[BOM: 524075|NSE : ALBERTDAVD]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹362 Cr | ₹342 Cr | ₹314 Cr | ₹247 Cr | ₹321 Cr |
| Expenses | ₹315 Cr | ₹297 Cr | ₹273 Cr | ₹228 Cr | ₹290 Cr |
| Operating Profit (Excl OI) | ₹47 Cr | ₹44 Cr | ₹41 Cr | ₹19 Cr | ₹31 Cr |
| Other Income | ₹58 Cr | ₹15 Cr | ₹16 Cr | ₹17 Cr | ₹7.11 Cr |
| Interest | ₹0.43 Cr | ₹0.58 Cr | ₹0.67 Cr | ₹0.78 Cr | ₹0.99 Cr |
| Depreciation | ₹6.83 Cr | ₹8.55 Cr | ₹8.81 Cr | ₹8.23 Cr | ₹7.68 Cr |
| Profit Before Tax | ₹97 Cr | ₹51 Cr | ₹47 Cr | ₹27 Cr | ₹29 Cr |
| Profit After Tax | ₹75 Cr | ₹36 Cr | ₹35 Cr | ₹22 Cr | ₹19 Cr |
| Earnings Per Share (Rs) | ₹132.15 | ₹63.38 | ₹61.78 | ₹38.80 | ₹33.59 |
| PAT Margin (%) | 19.67 | 10.03 | 10.66 | 8.50 | 5.68 |
| ROE(%) | 21.72 | 12.24 | 13.46 | 9.48 | 8.85 |
| ROCE(%) | 27.84 | 17.10 | 18.10 | 11.99 | 13.74 |
| Total Debt/Equity(x) | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 |
Key Financials |
||
| Market Cap | : | ₹ 698.2 Cr |
| Revenue (TTM) | : | ₹ 365.1 Cr |
| Net Profit(TTM) | : | ₹ 68.5 Cr |
| EPS (TTM) | : | ₹ 120.3 |
| P/E (TTM) | : | 10.2 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ALBERT DAVID | 0.1% | -6.4% | -2.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 2.6% | -1.1% | 38.3% |
| CIPLA | -2.4% | -5.2% | 10.6% |
| DR REDDYS LABORATORIES | -5.9% | -9.6% | 14.5% |
| ZYDUS LIFESCIENCES | -3.9% | -0.3% | 40.6% |
| DIVIS LABORATORIES | -3.8% | -1.9% | 60.1% |
| MANKIND PHARMA | -7.4% | -14% | 21.4% |
| TORRENT PHARMACEUTICALS | 2.6% | -5% | 29% |
| LUPIN | 0.1% | -2.2% | 52.5% |
ALBERT DAVID Revenues
[BOM: 524075|NSE : ALBERTDAVD]
| Y-o-Y | 6.12 % |
| 5 Yr CAGR | 3.10 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹362 Cr | 6.12 | |
| Mar2023 | ₹342 Cr | 8.95 | |
| Mar2022 | ₹314 Cr | 26.70 | |
| Mar2021 | ₹247 Cr | -22.86 | |
| Mar2020 | ₹321 Cr | - | |
ALBERT DAVID Operating Profit
[BOM: 524075|NSE : ALBERTDAVD]
| Y-o-Y | 5.66 % |
| 5 Yr CAGR | 11.41 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹47 Cr | 5.66 | |
| Mar2023 | ₹44 Cr | 8.64 | |
| Mar2022 | ₹41 Cr | 112.32 | |
| Mar2021 | ₹19 Cr | -36.80 | |
| Mar2020 | ₹31 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -0.46 % |
| 5 Yr CAGR | 8.05 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 12.96% | -0.46 | |
| Mar2023 | 13.02% | -0.31 | |
| Mar2022 | 13.06% | 67.65 | |
| Mar2021 | 7.79% | -18.09 | |
| Mar2020 | 9.51% | - | |
ALBERT DAVID Profit After Tax
[BOM: 524075|NSE : ALBERTDAVD]
| Y-o-Y | 108.49 % |
| 5 Yr CAGR | 40.84 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹75 Cr | 108.49 | |
| Mar2023 | ₹36 Cr | 2.60 | |
| Mar2022 | ₹35 Cr | 59.23 | |
| Mar2021 | ₹22 Cr | 15.51 | |
| Mar2020 | ₹19 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 96.11 % |
| 5 Yr CAGR | 36.42 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 19.67 % | 96.11 | |
| Mar2023 | 10.03 % | -5.91 | |
| Mar2022 | 10.66 % | 25.41 | |
| Mar2021 | 8.5 % | 49.65 | |
| Mar2020 | 5.68 % | - | |
ALBERT DAVID Earnings Per Share (EPS)
[BOM: 524075|NSE : ALBERTDAVD]
| Y-o-Y | 108.50 % |
| 5 Yr CAGR | 40.84 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹132 | 108.50 | |
| Mar2023 | ₹63 | 2.59 | |
| Mar2022 | ₹62 | 59.23 | |
| Mar2021 | ₹39 | 15.51 | |
| Mar2020 | ₹34 | - | |
ALBERT DAVID Return on Capital Employed (ROCE)
[BOM: 524075|NSE : ALBERTDAVD]
| Y-o-Y | 62.81 % |
| 5 Yr CAGR | 19.31 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 27.84% | 62.81 | |
| Mar2023 | 17.1% | -5.52 | |
| Mar2022 | 18.1% | 50.96 | |
| Mar2021 | 11.99% | -12.74 | |
| Mar2020 | 13.74% | - | |
ALBERT DAVID Share Price vs Sensex
| Current Share Price | : | ₹1,224.9 |
| Current MarketCap | : | ₹ 698.2 Cr |
| Updated EOD on | : | Jan 24,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 0.1% |
-6.4% |
-2.8% |
| SENSEX | -0.6% |
-2.9% |
6.3% |
ALBERT DAVID related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about ALBERT DAVID Financials
How the annual revenues of ALBERT DAVID have changed ?
The Revenues of ALBERT DAVID have increased by 6.12% YoY .
How the Earnings per Share (EPS) of ALBERT DAVID have changed?
The Earnings Per Share (EPS) of ALBERT DAVID has increased by 108.50 % YoY .
Check out Intrinsic Value of Peers of ALBERT DAVID
Compare Stock Analytics of Peers of ALBERT DAVID
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
